查看文章

V De Weger, MP Lolkema, M Dickson, A Le Cesne, A Wagner, M Merqui-Roelvink, A Varga, W Tap, G Schwartz, G Demetri, W Zheng, G Tuffal, S Mace, H Miao, JHM Schellens, M de Jonge

2014

European Journal of Cancer

50

121-122

378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies × Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser. I accept Polski English Login or register account remember me Password recovery INFONA - …